title: [The Avastin-Lucentis case: between protection of the competition and public health].
authors.affiliation: Centro nazionale di epidemiologia, sorveglianza e promozione della salute (CNESPS), Istituto superiore di sanità, Roma giuseppe.traversa@iss.it.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Traversa
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D016363:Antitrust Laws; D000068258:Bevacizumab / Q000627:therapeutic use; D004345:Drug Industry / Q000331:legislation & jurisprudence; D004465:Economic Competition / Q000331:legislation & jurisprudence; D006801:Humans; D011634:Public Health; D000069579:Ranibizumab / Q000627:therapeutic use
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab; D000069579:Ranibizumab